메뉴 건너뛰기




Volumn 172, Issue 23, 2015, Pages 5690-5703

Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: A correlation with the inhibition of carbonyl reductase-mediated metabolism

Author keywords

[No Author keywords available]

Indexed keywords

23 HYDROXYBETULINIC ACID; ASPARTATE AMINOTRANSFERASE; CARBONYL REDUCTASE; CARBONYL REDUCTASE 1; CREATINE KINASE; DOXORUBICIN; DOXORUBICINOL; LACTATE DEHYDROGENASE; PENTACYCLIC TRITERPENE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 23-HYDROXYBETULINIC ACID; ALCOHOL DEHYDROGENASE; ENZYME INHIBITOR; TRITERPENE;

EID: 84949529495     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12995     Document Type: Article
Times cited : (33)

References (38)
  • 1
    • 84858193763 scopus 로고    scopus 로고
    • Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity
    • Ahmed F, Urooj A, (2012). Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity. Pharm Biol 50: 468-473.
    • (2012) Pharm Biol , vol.50 , pp. 468-473
    • Ahmed, F.1    Urooj, A.2
  • 3
    • 66449103252 scopus 로고    scopus 로고
    • Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin
    • Bains OS, Karkling MJ, Grigliatti TA, Reid RE, Riggs KW, (2009). Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin. Drug Metab Dispos 37: 1107-1114.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1107-1114
    • Bains, O.S.1    Karkling, M.J.2    Grigliatti, T.A.3    Reid, R.E.4    Riggs, K.W.5
  • 4
    • 78649613721 scopus 로고    scopus 로고
    • Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin
    • Bains OS, Grigliatti TA, Reid RE, Riggs KW, (2010). Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin. J Pharmacol Exp Ther 335: 533-545.
    • (2010) J Pharmacol Exp Ther , vol.335 , pp. 533-545
    • Bains, O.S.1    Grigliatti, T.A.2    Reid, R.E.3    Riggs, K.W.4
  • 5
    • 46049104446 scopus 로고    scopus 로고
    • Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinine oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
    • Blanco JG, Leisenring WM, Gonzalez-Covarrubias VM, Kawashima TI, Davies SM, Relling MV, et al. (2008). Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinine oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 112: 2789-2795.
    • (2008) Cancer , vol.112 , pp. 2789-2795
    • Blanco, J.G.1    Leisenring, W.M.2    Gonzalez-Covarrubias, V.M.3    Kawashima, T.I.4    Davies, S.M.5    Relling, M.V.6
  • 8
    • 59349113924 scopus 로고    scopus 로고
    • Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis
    • El-Hawari Y1, Favia AD, Pilka ES, Kisiela M, Oppermann U, Martin HJ, et al. (2009). Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis. Chem Biol Interact 178: 234-241.
    • (2009) Chem Biol Interact , vol.178 , pp. 234-241
    • El-Hawari, Y.1    Favia, A.D.2    Pilka, E.S.3    Kisiela, M.4    Oppermann, U.5    Martin, H.J.6
  • 10
    • 0034665414 scopus 로고    scopus 로고
    • Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice
    • Forrest GL, Gonzalez B, Tseng W, Li X, Mann J, (2002). Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice. Cancer Res 60: 5158-5164.
    • (2002) Cancer Res , vol.60 , pp. 5158-5164
    • Forrest, G.L.1    Gonzalez, B.2    Tseng, W.3    Li, X.4    Mann, J.5
  • 11
    • 44749085662 scopus 로고    scopus 로고
    • Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)
    • Gonzalez-Covarrubias V1, Kalabus JL, Blanco JG, (2008). Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER). Pharm Res 25: 1730-1734.
    • (2008) Pharm Res , vol.25 , pp. 1730-1734
    • Gonzalez-Covarrubias, V.1    Kalabus, J.L.2    Blanco, J.G.3
  • 12
    • 84898809667 scopus 로고    scopus 로고
    • Insights into drug discovery from natural medicines using reverse pharmacokinetics
    • Hao H, Zheng X, Wang G, (2014). Insights into drug discovery from natural medicines using reverse pharmacokinetics. Trends Pharmacol Sci 35: 168-177.
    • (2014) Trends Pharmacol Sci , vol.35 , pp. 168-177
    • Hao, H.1    Zheng, X.2    Wang, G.3
  • 13
    • 0029796045 scopus 로고    scopus 로고
    • The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells
    • Hasinoff BB, Yalowich JC, Ling Y, Buss JL, (1996). The effect of dexrazoxane (ICRF-187) on doxorubicin- and daunorubicin-mediated growth inhibition of Chinese hamster ovary cells. Anticancer Drugs 7: 558-567.
    • (1996) Anticancer Drugs , vol.7 , pp. 558-567
    • Hasinoff, B.B.1    Yalowich, J.C.2    Ling, Y.3    Buss, J.L.4
  • 14
    • 0033025348 scopus 로고    scopus 로고
    • The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis
    • Hasinoff BB, Chee GL, Thampatty P, Allan WP, Yalowich JC, (1999). The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis. Anticancer Drugs 10: 47-54.
    • (1999) Anticancer Drugs , vol.10 , pp. 47-54
    • Hasinoff, B.B.1    Chee, G.L.2    Thampatty, P.3    Allan, W.P.4    Yalowich, J.C.5
  • 15
    • 0037159593 scopus 로고    scopus 로고
    • 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells
    • Ji ZN, Ye WC, Liu GG, Hsiao W, (2002). 23-Hydroxybetulinic acid-mediated apoptosis is accompanied by decreases in bcl-2 expression and telomerase activity in HL-60 Cells. Life Sci 72: 1-9.
    • (2002) Life Sci , vol.72 , pp. 1-9
    • Ji, Z.N.1    Ye, W.C.2    Liu, G.G.3    Hsiao, W.4
  • 16
    • 80051646543 scopus 로고    scopus 로고
    • Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy
    • Kang A, Hao H, Zheng X, Liang Y, Xie Y, Xie T, et al. (2011). Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy. J Neuroinflammation 8: 100.
    • (2011) J Neuroinflammation , vol.8 , pp. 100
    • Kang, A.1    Hao, H.2    Zheng, X.3    Liang, Y.4    Xie, Y.5    Xie, T.6
  • 19
    • 77950815766 scopus 로고    scopus 로고
    • Pharmacogenetics of target genes across doxorubicin disposition pathway: A review
    • Lal S, Mahajan A, Chen WN, Chowbay B, (2010). Pharmacogenetics of target genes across doxorubicin disposition pathway: a review. Curr Drug Metab 11: 115-128.
    • (2010) Curr Drug Metab , vol.11 , pp. 115-128
    • Lal, S.1    Mahajan, A.2    Chen, W.N.3    Chowbay, B.4
  • 20
    • 77954331629 scopus 로고    scopus 로고
    • Guidelines for reporting experiments involving animals: The ARRIVE guidelines
    • McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
    • (2010) Br J Pharmacol , vol.160 , pp. 1573-1576
    • McGrath, J.1    Drummond, G.2    McLachlan, E.3    Kilkenny, C.4    Wainwright, C.5
  • 21
    • 34548301536 scopus 로고    scopus 로고
    • An introduction to the metabolic determinants of anthracycline cardiotoxicity
    • Menna P, Recalcati S, Cairo G, Minotti G, (2007). An introduction to the metabolic determinants of anthracycline cardiotoxicity. Cardiovasc Toxicol 7: 80-85.
    • (2007) Cardiovasc Toxicol , vol.7 , pp. 80-85
    • Menna, P.1    Recalcati, S.2    Cairo, G.3    Minotti, G.4
  • 22
    • 70350787143 scopus 로고    scopus 로고
    • Aldo-keto reductase (AKR) superfamily: Genomics and annotation
    • Mindnich RD, Penning TM, (2009). Aldo-keto reductase (AKR) superfamily: genomics and annotation. Hum Genomics 3: 362-370.
    • (2009) Hum Genomics , vol.3 , pp. 362-370
    • Mindnich, R.D.1    Penning, T.M.2
  • 23
    • 0035576817 scopus 로고    scopus 로고
    • Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: Evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy
    • Minotti G, Ronchi R, Salvatorelli E, Menna P, Cairo G, (2001). Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res 61: 8422-8488.
    • (2001) Cancer Res , vol.61 , pp. 8422-8488
    • Minotti, G.1    Ronchi, R.2    Salvatorelli, E.3    Menna, P.4    Cairo, G.5
  • 24
    • 0041694227 scopus 로고    scopus 로고
    • Anthracycline secondary alcohol metabolite formation in human or rabbit heart: Biochemical aspects and pharmacologic implications
    • Mordente A, Minotti G, Martorana GE, Silvestrini A, Giardina B, Meucci E, (2003). Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications. Biochem Pharmacol 66: 989-998.
    • (2003) Biochem Pharmacol , vol.66 , pp. 989-998
    • Mordente, A.1    Minotti, G.2    Martorana, G.E.3    Silvestrini, A.4    Giardina, B.5    Meucci, E.6
  • 25
    • 0242321133 scopus 로고    scopus 로고
    • Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1
    • Olson LE, Bedja D, Alvey SJ, Cardounel AJ, Gabrielson KL, Reeves RH, (2003). Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1. Cancer Res 63: 6602-6606.
    • (2003) Cancer Res , vol.63 , pp. 6602-6606
    • Olson, L.E.1    Bedja, D.2    Alvey, S.J.3    Cardounel, A.J.4    Gabrielson, K.L.5    Reeves, R.H.6
  • 26
    • 84891791940 scopus 로고    scopus 로고
    • The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
    • NC-IUPHAR. (Database Issue)
    • Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-1106.
    • (2014) Nucl Acids Res , vol.42 , pp. D1098-D1106
    • Pawson, A.J.1    Sharman, J.L.2    Benson, H.E.3    Faccenda, E.4    Alexander, S.P.5    Buneman, O.P.6
  • 27
    • 79955655749 scopus 로고    scopus 로고
    • Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer
    • Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, et al. (2010). Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 4: 297-307.
    • (2010) Biosci Trends , vol.4 , pp. 297-307
    • Qi, F.1    Li, A.2    Inagaki, Y.3    Gao, J.4    Li, J.5    Kokudo, N.6
  • 28
    • 84859953907 scopus 로고    scopus 로고
    • Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin
    • Salvatorelli E, Menna P, Gonzalez Paz O, Surapaneni S, Aukerman SL, Chello M, et al. (2012). Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin. J Pharmacol Exp Ther 341: 474-483.
    • (2012) J Pharmacol Exp Ther , vol.341 , pp. 474-483
    • Salvatorelli, E.1    Menna, P.2    Gonzalez Paz, O.3    Surapaneni, S.4    Aukerman, S.L.5    Chello, M.6
  • 29
    • 84873836880 scopus 로고    scopus 로고
    • Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection
    • Stěrba M, Popelová O, Vávrová A, Jirkovský E, Kovaříková P, Geršl V, et al. (2013). Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal 18: 899-929.
    • (2013) Antioxid Redox Signal , vol.18 , pp. 899-929
    • Stěrba, M.1    Popelová, O.2    Vávrová, A.3    Jirkovský, E.4    Kovaříková, P.5    Geršl, V.6
  • 30
    • 33847096349 scopus 로고    scopus 로고
    • Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management
    • Takemura G, Fujiwara H, (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49: 330-352.
    • (2007) Prog Cardiovasc Dis , vol.49 , pp. 330-352
    • Takemura, G.1    Fujiwara, H.2
  • 31
    • 84876796922 scopus 로고    scopus 로고
    • Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice
    • Vinhas M, Araújo AC, Ribeiro S, Rosário LB, Belo JA, (2013). Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice. Cardiovasc Ultrasound 11: 12. doi: 10.1186/1476-7120-11-12.
    • (2013) Cardiovasc Ultrasound , vol.11 , pp. 12
    • Vinhas, M.1    Araújo, A.C.2    Ribeiro, S.3    Rosário, L.B.4    Belo, J.A.5
  • 32
    • 33646002630 scopus 로고    scopus 로고
    • Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models
    • Xie X, Eberding A, Madera C, Fazli L, Jia W, Goldenberg L, et al. (2006). Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models. J Urol 175: 1926-1931.
    • (2006) J Urol , vol.175 , pp. 1926-1931
    • Xie, X.1    Eberding, A.2    Madera, C.3    Fazli, L.4    Jia, W.5    Goldenberg, L.6
  • 33
    • 84868538356 scopus 로고    scopus 로고
    • BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo
    • Zhang DM, Shu C, Chen JJ, Sodani K, Wang J, Bhatnagar J, et al. (2012a). BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo. Mol Pharm 9: 3147-3159.
    • (2012) Mol Pharm , vol.9 , pp. 3147-3159
    • Zhang, D.M.1    Shu, C.2    Chen, J.J.3    Sodani, K.4    Wang, J.5    Bhatnagar, J.6
  • 34
    • 78649580065 scopus 로고    scopus 로고
    • 20(S)-ginsenoside rh2 noncompetitively inhibits p-glycoprotein in vitro and in vivo: A case for herb-drug interactions
    • Zhang J, Zhou F, Wu X, Gu Y, Ai H, Zheng Y, et al. (2010). 20(S)-ginsenoside rh2 noncompetitively inhibits p-glycoprotein in vitro and in vivo: a case for herb-drug interactions. Drug Metab Dispos 38: 2179-2187.
    • (2010) Drug Metab Dispos , vol.38 , pp. 2179-2187
    • Zhang, J.1    Zhou, F.2    Wu, X.3    Gu, Y.4    Ai, H.5    Zheng, Y.6
  • 35
    • 82955184560 scopus 로고    scopus 로고
    • Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells
    • Zhang J, Zhou F, Wu X, Zhang X, Chen Y, Zha BS, et al. (2012b). Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells. Br J Pharmacol 165: 120-134.
    • (2012) Br J Pharmacol , vol.165 , pp. 120-134
    • Zhang, J.1    Zhou, F.2    Wu, X.3    Zhang, X.4    Chen, Y.5    Zha, B.S.6
  • 36
    • 77951206515 scopus 로고    scopus 로고
    • 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo
    • Zheng Y, Zhou F, Wu X, Wen X, Li Y, Yan B, et al. (2010). 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J Ethnopharmacol 128: 615-622.
    • (2010) J Ethnopharmacol , vol.128 , pp. 615-622
    • Zheng, Y.1    Zhou, F.2    Wu, X.3    Wen, X.4    Li, Y.5    Yan, B.6
  • 37
    • 34848914074 scopus 로고    scopus 로고
    • Synthesis and antitumor activity of derivatives of 23-hydroxybetulinic acid
    • Zhou JP, Li D, Wu XM, Ye WC, Zhang LY, (2007). Synthesis and antitumor activity of derivatives of 23-hydroxybetulinic acid. Chin Chem Lett 18: 1195-1198.
    • (2007) Chin Chem Lett , vol.18 , pp. 1195-1198
    • Zhou, J.P.1    Li, D.2    Wu, X.M.3    Ye, W.C.4    Zhang, L.Y.5
  • 38
    • 0037274873 scopus 로고    scopus 로고
    • Cardiac toxicity of antineoplastic anthracyclines
    • Zucchi R, Danesi R, (2003). Cardiac toxicity of antineoplastic anthracyclines. Curr Med Chem Anticancer Agents 3: 151-171.
    • (2003) Curr Med Chem Anticancer Agents , vol.3 , pp. 151-171
    • Zucchi, R.1    Danesi, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.